186 related articles for article (PubMed ID: 36812307)
1. PI3-kinase deletion promotes myelodysplasia by dysregulating autophagy in hematopoietic stem cells.
Ames K; Kaur I; Shi Y; Tong MM; Sinclair T; Hemmati S; Glushakow-Smith SG; Tein E; Gurska L; Steidl U; Dubin R; Shan J; Montagna C; Pradhan K; Verma A; Gritsman K
Sci Adv; 2023 Feb; 9(8):eade8222. PubMed ID: 36812307
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the Link between Class 1A PI3-Kinase, Autophagy, and Myelodysplasia.
Ames K; Gritsman K
Autophagy; 2024 Apr; 20(4):952-954. PubMed ID: 37289024
[TBL] [Abstract][Full Text] [Related]
3. Quercetin induces autophagy in myelodysplastic bone marrow including hematopoietic stem/progenitor compartment.
Daw S; Law S
Environ Toxicol; 2021 Feb; 36(2):149-167. PubMed ID: 32902906
[TBL] [Abstract][Full Text] [Related]
4. Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes.
Falconi G; Fabiani E; Fianchi L; Criscuolo M; Raffaelli CS; Bellesi S; Hohaus S; Voso MT; D'Alò F; Leone G
Exp Hematol; 2016 Jan; 44(1):75-83.e1-4. PubMed ID: 26521017
[TBL] [Abstract][Full Text] [Related]
5. Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion.
Perry JM; He XC; Sugimura R; Grindley JC; Haug JS; Ding S; Li L
Genes Dev; 2011 Sep; 25(18):1928-42. PubMed ID: 21890648
[TBL] [Abstract][Full Text] [Related]
6. Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS.
An N; Khan S; Imgruet MK; Gurbuxani SK; Konecki SN; Burgess MR; McNerney ME
Blood; 2018 Jun; 131(24):2682-2697. PubMed ID: 29592892
[TBL] [Abstract][Full Text] [Related]
7. Phagocytosis checkpoints on hematopoietic stem cells in patients with myelodysplastic syndromes.
Dong X; Han Y; Liu Y; Yang L; Niu H; Yan L; Liu C; Shao Z; Xing L; Wang H
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e119-e128. PubMed ID: 34152084
[TBL] [Abstract][Full Text] [Related]
8. Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression.
Magee JA; Ikenoue T; Nakada D; Lee JY; Guan KL; Morrison SJ
Cell Stem Cell; 2012 Sep; 11(3):415-28. PubMed ID: 22958933
[TBL] [Abstract][Full Text] [Related]
9. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
[TBL] [Abstract][Full Text] [Related]
10. Advances in MDS/AML and inositide signalling.
De Stefano A; Marvi MV; Fazio A; McCubrey JA; Suh PG; Ratti S; Ramazzotti G; Manzoli L; Cocco L; Follo MY
Adv Biol Regul; 2023 Jan; 87():100955. PubMed ID: 36706610
[TBL] [Abstract][Full Text] [Related]
11. Increased Ripk1-mediated bone marrow necroptosis leads to myelodysplasia and bone marrow failure in mice.
Wagner PN; Shi Q; Salisbury-Ruf CT; Zou J; Savona MR; Fedoriw Y; Zinkel SS
Blood; 2019 Jan; 133(2):107-120. PubMed ID: 30413413
[TBL] [Abstract][Full Text] [Related]
12. Atp8a1 deletion increases the proliferative activity of hematopoietic stem cells by impairing PTEN function.
Zheng L; Pan C; Tian W; Liang C; Feng Y; He W; Yang Z; Wang B; Qiu Q; Li N; Sun Y; Qiu H; Sample KM; Zhou L; Zhu X; Hu Y
Cell Oncol (Dordr); 2023 Aug; 46(4):1069-1083. PubMed ID: 36930333
[TBL] [Abstract][Full Text] [Related]
13. Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks.
Sundaravel S; Kuo WL; Jeong JJ; Choudhary GS; Gordon-Mitchell S; Liu H; Bhagat TD; McGraw KL; Gurbuxani S; List AF; Verma A; Wickrema A
Clin Cancer Res; 2019 Sep; 25(18):5638-5649. PubMed ID: 31308061
[TBL] [Abstract][Full Text] [Related]
14. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.
Follo MY; Mongiorgi S; Bosi C; Cappellini A; Finelli C; Chiarini F; Papa V; Libra M; Martinelli G; Cocco L; Martelli AM
Cancer Res; 2007 May; 67(9):4287-94. PubMed ID: 17483341
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway.
Roversi FM; Pericole FV; Machado-Neto JA; da Silva Santos Duarte A; Longhini AL; Corrocher FA; Palodetto B; Ferro KP; Rosa RG; Baratti MO; Verjovski-Almeida S; Traina F; Molinari A; Botta M; Saad ST
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):450-461. PubMed ID: 27840303
[TBL] [Abstract][Full Text] [Related]
16. Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome.
Bereshchenko O; Lo Re O; Nikulenkov F; Flamini S; Kotaskova J; Mazza T; Le Pannérer MM; Buschbeck M; Giallongo C; Palumbo G; Li Volti G; Pazienza V; Cervinek L; Riccardi C; Krejci L; Pospisilova S; Stewart AF; Vinciguerra M
Clin Epigenetics; 2019 Aug; 11(1):121. PubMed ID: 31439048
[TBL] [Abstract][Full Text] [Related]
17. Constitutive MAP kinase activation in hematopoietic stem cells induces a myeloproliferative disorder.
Chung E; Hsu CL; Kondo M
PLoS One; 2011; 6(12):e28350. PubMed ID: 22164275
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes.
Abbas S; Kini A; Srivastava VM; M MT; Nair SC; Abraham A; Mathews V; George B; Kumar S; Venkatraman A; Srivastava A
Blood Cells Mol Dis; 2017 Jul; 66():37-46. PubMed ID: 28822917
[TBL] [Abstract][Full Text] [Related]
19. Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice.
An N; Kraft AS; Kang Y
J Hematol Oncol; 2013 Jan; 6():12. PubMed ID: 23360755
[TBL] [Abstract][Full Text] [Related]
20. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
Nilsson L; Astrand-Grundström I; Anderson K; Arvidsson I; Hokland P; Bryder D; Kjeldsen L; Johansson B; Hellström-Lindberg E; Hast R; Jacobsen SE
Blood; 2002 Jul; 100(1):259-67. PubMed ID: 12070035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]